Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study With Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

NCT00804830 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT00804830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00804830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study With Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Lead sponsor
Region Skane
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2008
Completion date
December 31, 2014
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, metastatic cancer, thyroid cancer, thyroid neoplasms